OINDP device manufacturer Aptar Pharma recently broke ground on new manufacturing facility on a 3.5 acre site in Mumbai, India, with the groundbreaking taking place on the tenth anniversary of the existing Aptar facility in Mumbai, the company said. Construction on the new facility is expected to be complete by the first quarter of 2023.
Aptar President and CEO Stephan Tanda said, “Over the years, our pharma business in India has shown robust growth and so, in order to serve the needs of our Indian customers, we are enhancing our manufacturing capabilities. Our new facility is a key step that strengthens our competitive position and brings global technology to India, which will ultimately benefit patients.”
Aptar President, India and SEA, Kanwal Tikoo commented, Aptar Pharma has established market leadership position as a pharma packaging solutions company and we continue to grow our influence in this part of the world as the go-to drug delivery expert. We continue to help our customers succeed and patients to live a better life.”
Read the Aptar press release.
